
Morgan Stanley downgraded Genting Singapore (GENS:SP) to Underweight from Equalweight, lowering its price target to SGD0.70 from SGD0.85, following disappointing Q2 2025 results that significantly missed consensus estimates for EBITDA and net profit. The firm reduced its 2025 and 2026 EBITDA forecasts and adjusted its valuation methodology, anticipating continued negative earnings revisions despite the company's strong balance sheet metrics like a 5.21x current ratio and zero debt. This downgrade signals a cautious outlook from the bank, positioning its estimates below market consensus and suggesting potential further stock pressure.
Morgan Stanley has downgraded Genting Singapore to Underweight from Equalweight, cutting its price target to SGD0.70 from SGD0.85, signaling a bearish outlook driven by operational underperformance. The downgrade follows a significant second-quarter 2025 earnings miss, where both EBITDA and net profit fell short of consensus estimates; on an annualized basis, these figures would only reach 75% and 80% of full-year consensus, respectively. In response, the bank has lowered its 2025 and 2026 EBITDA forecasts by 5% and 6%, placing them below market consensus and anticipating further negative earnings revisions. This valuation shift is further reinforced by an increase in the target free cash flow to equity (FCFE) yield from 7% to 8%. This negative operational outlook from Morgan Stanley contrasts sharply with the company's robust balance sheet, which features a current ratio of 5.21x, zero debt, and a consistent capital return policy highlighted by a 4.67% dividend yield and three consecutive years of dividend increases.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly negative
Sentiment Score
-0.30
Ticker Sentiment